We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

PAY:NYSEPaymentus Holdings, Inc. Analysis

Data as of 2026-06-26 - not real-time

$23.30

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Paymentus posted a record Q1 revenue of $358.4 million, reflecting a **30.2% year‑over‑year growth** and an adjusted EBITDA margin approaching 39%, underscoring the strength of its SaaS platform. Operating cash flow remains healthy at $142 million**, and the balance sheet is fortified by $339 million in cash against minimal debt. The stock trades at a **trailing P/E of 40.9**, well above the software‑infrastructure industry average of 36.3, suggesting a premium valuation, yet the **DCF‑derived fair value of $29.4** indicates roughly a 47% upside from the current $23.3 price. Technicals show the price sitting above the 20‑day SMA (21.5) but below the 50‑day SMA (24.4), with a bearish trend label but a bullish MACD histogram, highlighting mixed short‑term signals. Volatility is elevated at over 52% on a 30‑day basis, and the beta is modest, implying price swings are more company‑specific than market‑driven. Overall, the combination of robust top‑line growth, improving profitability, and a sizable valuation gap supports a **cautiously optimistic** outlook, provided investors can tolerate the near‑term price volatility.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price near short‑term resistance at $24.38
  • High 30‑day volatility (~53%)
  • Recent earnings beat and strong cash flow

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Sustained revenue growth of ~30% YoY
  • DCF upside of ~47% versus current price
  • Improving EBITDA margins and low leverage

Long Term

> 3 years
Positive
Model confidence: 7/10

Key Factors

  • Recurring SaaS revenue model with expanding biller base
  • Solid ROE (~13.6%) and ROA (~8.4%)
  • Limited regulatory headwinds and primarily USD exposure

Key Metrics & Analysis

Financial Health

Revenue Growth30.20%
Profit Margin5.78%
P/E Ratio40.9
ROE13.66%
ROA8.38%
Debt/Equity1.14
P/B Ratio5.0
Op. Cash Flow$142.1M
Free Cash Flow$92.3M
Industry P/E36.3

Technical Analysis

TrendBearish
RSI56.1
Support$20.11
Resistance$24.38
MA 20$21.49
MA 50$24.40
MA 200$28.28
MACDBullish
VolumeStable
Fear & Greed Index87.89

Valuation

Fair Value$29.41
Target Price$34.29
Upside/Downside47.15%
GradeUndervalued
TypeBlend

Risk Assessment

Beta0.64
Volatility52.69%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.